Does ERTUGLIFLOZIN PIDOLATE Cause Diabetic ketoacidosis? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Diabetic ketoacidosis have been filed in association with ERTUGLIFLOZIN PIDOLATE (STEGLATRO). This represents 5.0% of all adverse event reports for ERTUGLIFLOZIN PIDOLATE.
34
Reports of Diabetic ketoacidosis with ERTUGLIFLOZIN PIDOLATE
5.0%
of all ERTUGLIFLOZIN PIDOLATE reports
0
Deaths
30
Hospitalizations
How Dangerous Is Diabetic ketoacidosis From ERTUGLIFLOZIN PIDOLATE?
Of the 34 reports, 30 (88.2%) required hospitalization, and 11 (32.4%) were considered life-threatening.
Is Diabetic ketoacidosis Listed in the Official Label?
Yes, Diabetic ketoacidosis is listed as a known adverse reaction in the official FDA drug label for ERTUGLIFLOZIN PIDOLATE.
What Other Side Effects Does ERTUGLIFLOZIN PIDOLATE Cause?
Fungal infection (58)
Product dose omission issue (57)
Nausea (55)
No adverse event (53)
Urinary tract infection (52)
Dizziness (33)
Vomiting (31)
Blood glucose increased (30)
Product dose omission (27)
Drug ineffective (21)
What Other Drugs Cause Diabetic ketoacidosis?
EMPAGLIFLOZIN (3,644)
CANAGLIFLOZIN (3,413)
DAPAGLIFLOZIN (1,773)
METFORMIN (1,584)
INSULIN ASPART (1,398)
INSULIN LISPRO (924)
INSULIN GLARGINE (776)
NIVOLUMAB (687)
DAPAGLIFLOZIN PROPANEDIOL (547)
PEMBROLIZUMAB (397)
Which ERTUGLIFLOZIN PIDOLATE Alternatives Have Lower Diabetic ketoacidosis Risk?
ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN
ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN ETHYLSUCCINATE
ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN LACTOBIONATE
ERTUGLIFLOZIN PIDOLATE vs ERYTHROPOIETIN
ERTUGLIFLOZIN PIDOLATE vs ESCHERICHIA COLI